Preoperative anti-PF4/heparin antibody level predicts adverse outcome after cardiac surgery
- 1 December 2005
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 130 (6) , 1567-1572
- https://doi.org/10.1016/j.jtcvs.2005.07.052
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Heparin-induced thrombocytopeniaJournal of Thrombosis and Haemostasis, 2003
- Anti-Platelet Factor 4/Heparin AntibodiesCirculation, 2003
- Aspirin and Mortality from Coronary Bypass SurgeryNew England Journal of Medicine, 2002
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Antibodies to Platelet Factor 4–Heparin After Cardiopulmonary Bypass in Patients Anticoagulated With Unfractionated Heparin or a Low-Molecular-Weight HeparinCirculation, 1999
- Heparin-associated Thrombocytopenia and ThrombosisAnesthesiology, 1997
- Prevalence of Heparin-Associated Antibodies Without Thrombosis in Patients Undergoing Cardiopulmonary Bypass SurgeryCirculation, 1997
- AnnotationBritish Journal of Haematology, 1995
- Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognitionThe Annals of Thoracic Surgery, 1992
- The release of β‐ thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgeryEuropean Journal of Clinical Investigation, 1981